Abacus LifeNASDAQ: ABL

ORLANDO, Fla., June 24, 2024 (GLOBE NEWSWIRE) -- Abacus Life, Inc. (“Abacus” or the “Company”) (NASDAQ: ABL), a pioneering alternative asset manager specializing in longevity and actuarial technology, today announced the closing of its oversubscribed underwritten public offering of 11,500,000 shares of its common stock, including the exercise in full by the underwriters of their option to purchase an additional 1,500,000 shares of common stock, at the public offering price of $8.00 per share. The gross proceeds raised in the offering, before underwriting discounts and commissions and estimated expenses of the offering, were approximately $92 million.

ORLANDO, Fla., June 20, 2024 (GLOBE NEWSWIRE) -- Abacus Life, Inc. (“Abacus” or the “Company”) (NASDAQ: ABL), a pioneering alternative asset manager specializing in longevity and actuarial technology, today announced the pricing of its oversubscribed underwritten public offering of 10,000,000 shares of its common stock at a price to the public of $8.00 per share. In connection with the offering, the Company also granted the underwriters a 30-day option to purchase up to an additional 1,500,000 shares of common stock at the public offering price. The gross proceeds from the offering, before deducting underwriting discounts and commissions and offering expenses, are expected to be approximately $80 million, excluding any exercise of the underwriters' option to purchase additional shares. All of the shares in the public offering are to be sold by Abacus.

ORLANDO, Fla., June 13, 2024 (GLOBE NEWSWIRE) -- Abacus Life, Inc. (“Abacus” or the “Company”) (NASDAQ: ABL), a pioneering alternative asset manager specializing in longevity and actuarial technology, today announced that it has commenced an underwritten public offering of 10,000,000 shares of its common stock. In connection with the offering, Abacus intends to grant the underwriters a 30-day option to purchase up to an additional 1,500,000 shares of common stock at the public offering price. All of the shares in the public offering are to be sold by Abacus.

ORLANDO, Fla., June 06, 2024 (GLOBE NEWSWIRE) --  Abacus Life, Inc. (NASDAQ: ABL) (“Abacus” or the “Company”), a pioneering alternative asset manager specializing in longevity and actuarial technology, announced today that it led the life settlement industry in funds paid to clients in 2023 with a 26% market share according to The Deal, once again bringing premier value to its clients.

BARCELONA, Spain--(BUSINESS WIRE)--Wallbox, a global leader in electric vehicle (EV) charging and energy management solutions, announced a number of key strategic milestones since their acquisition of ABL, an industry pioneer and German leader in EV charging. The integration of ABL into the Wallbox Group has already yielded encouraging results that will strengthen both companies' ability to support the EV transition. "We are immensely proud of what we have achieved in the first six months follo.

Abacus Life, Inc. (NASDAQ:ABL) Q1 2024 Earnings Conference Call on May 13, 2024 at 9:00 AM ET with company representatives Garrett Edson, Jay Jackson, and Bill McCauley. Conference call participants include Wilma Burdis, Andrew Kligerman, and Matthew Howlett from Raymond James, TD Cowen, and B. Riley Securities, respectively. Welcome to the Abacus Life First Quarter 2024 Earnings Call.

Abacus Life, Inc. (ABL) Q4 2023 Earnings Call Transcript

New Exchange Preferred Stock And Traded Debt IPOs, November 2023